Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1997-04-22
1998-09-01
Stucker, Jeffrey
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
435 71, 435 72, 435 725, 435 79, 435 792, 435 794, 435974, 435975, 436518, 436519, 436520, 436521, 436526, 436528, 436530, 436533, 530326, 530806, 530812, 530826, C12Q 170
Patent
active
058009833
ABSTRACT:
HIV-1 peptides having at least one point mutation between position 593 and 611 of the HIV-1 gp160 amino acid sequence. The point mutation either is at position 604 or 610, or both positions. Immunoassays which utilize these peptides are provided, as well as, diagnostic test kits which contain these peptides.
REFERENCES:
patent: 5075077 (1991-12-01), Durley, III et al.
patent: 5304466 (1994-04-01), De Leys et al.
patent: 5320808 (1994-06-01), Holen et al.
patent: 5374518 (1994-12-01), Hunt et al.
W. Janssens et al., "Genetic and Phylofenetic Analysis of env Subtypes G and H in Central Africa", AIDS Research And Human Retroviruses, vol. 10, No.7,(1990), pp. 877-879.
N.R. Rose et al., "Immunoassay by Particle Counting", Manual Of Clinical Laboratory Immunology, 3rd edition, Chapter 8, (1996), pp. 43-48.
R. De Leys et al., "Isolation and Partial Characterzation of an Unusual Human Immunodeficiency Retrovirus from Two Persons of West-Central African Origin", Journal Of Virology, vol. 64, No. 3, (1990), pp. 1207-1216.
J.W. Gnaan, Jr. et al., "Synthetic Peptide Immunoassay Distinguishes HIV Type 1 and HIV Type 2 Infections", Science, vol. 237, (1987), pp. 1346-1349.
J.C. Hunt et al., "Discrimination Between HIV-1 and HIV-2 Seropositive Individuals Using Mouse Monoclonal Antibodies Directed to HIV Transmembrane Proteins", AIDS Research And Human Retroviruses, vol. 6, No. 7, (1990), pp. 883-898.
M.C. Cot et al., "Dual HIV-1 and HIV-2 Infection in West Africa Supported by Synthetic Peptide Analysis", AIDS Research And Human Retroviruses, vol 4, (1988), pp. 239-241.
L.G. Gurtler et al., "A New Subtype of Human Immunodeficiency Virus Type 1 (MVP-5180) from Cameroon", Journal Of Virology, vol. 68, No. 3, (1994), pp. 1581-1585.
I. Loussert-Ajaka et al., "HIV-1/HIV-2 Seronegativity in HIV-1 Subtype O Infected Patients", The Lancet, vol. 343, (1994), pp. 1393-1394.
M. Vanden Haesevelde et al., "Genomic Cloning and Complete Sequence Analysis of a Highly Divergent African Human Immunodeficiency Virus Isolate", Journal Of Virology, vol. 68, No. 3, (1994), pp. 1586-1596.
P. Charneau et al., "Isolation and Envelope Sequence of a Highly Divergent HIV-1 Isolate: Definition of a New HIV-1 Group", Virology, vol. 205, (1994), pp. 247-253.
Meyers et al., Human Retroviruses And Acids 1993: A Compilation And Analysis Of Nucleic Acid And Sequences, (Los Alamos National Laboratory, Los Alamos, NM), (1993).
Bridon Dominique P.
Colpitts Tracey L.
Daghfal David J.
Jaffe Keeve D.
Sze, deceased Isaac S.-Y.
Abbott Laboratories
Danckers Andreas M.
Stucker Jeffrey
LandOfFree
Peptides for HIV-1 detection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides for HIV-1 detection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for HIV-1 detection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-268850